Company Reports (Pharmaceutical) Market Research

Discover indepth market information on companies in Pharma & Healthcare. Our catalogue of reports provide detailed data on companies such as Wyeth, AstraZeneca Plc, Illumina Inc, and Johnson & Johnson.

Stay up-to-date with new products added to this category

Results 1 - 100 of 5395

previous 1 2 3 4 5 6 7 8 9 10 11 next

last

Title	Date	Price
Top 50 Pharmaceutical Companies Report : Global	Nov 2009	£820
Bayer Pipeline, Products ,Performance ,Potential	Oct 2009	£595
Boehringer Ingelheim: Pipeline, Products, Performance, Potential	Sep 2009	£595
Group Pharmaceuticals Ltd.-Company Report	Sep 2009	£455
GlycoMar Limited-Company Report	Sep 2009	£455
Grupo TechSphere-Company Report	Sep 2009	£455
Globalpharma Co LLC-Company Report	Sep 2009	£455
GreenPeptide Co., Ltd.-Company Report	Sep 2009	£455
Getwell Life Sciences India Pvt. Ltd.-Company Report	Sep 2009	£455
Genomma Lab Internacional, S.A.B de C.V.-Company Report	Sep 2009	£455
GenPharma International Pvt. Ltd.-Company Report	Sep 2009	£455
GTX INC/TN-Therapeutic Competitors	Sep 2009	£215
Gliknik Inc.-Company Report	Sep 2009	£455
GliaMed, Inc.-Company Report	Sep 2009	£455
Impax Laboratories Inc.-Therapeutic Competitors	Sep 2009	£215
Ipsen-Company Report	Sep 2009	£455
Intercept Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
Intellikine, Inc.-Company Report	Sep 2009	£455
Institut Rosell-Lallemand-Company Report	Sep 2009	£455
Impax Laboratories Inc.-Detailed Product Pipeline	Sep 2009	£455
Innovative Technologies-Company Report	Sep 2009	£455
Cytomedix Inc.-Deals & Alliances Report	Sep 2009	£365
Genopharm-Company Report	Sep 2009	£455
Inovio Biomedical Corporation-Therapeutic Competitors	Sep 2009	£215
Inovio Biomedical Corporation-Detailed Product Pipeline	Sep 2009	£455
GTX INC/TN-Detailed Product Pipeline	Sep 2009	£455
Genentech, Inc.-Company Report	Sep 2009	£455
Gilead Sciences Inc.: PharmaVitae Profile Healthcare	Sep 2009	£3,475
Feron Life Sciences-Company Report	Sep 2009	£455
Novo Nordisk A/S: PharmaVitae Profile Healthcare	Sep 2009	£3,475
FPL Pharma-Company Report	Sep 2009	£455
Fresenius SE-Company Report	Sep 2009	£455
FCB-Pharmicell Co.,Ltd.-Company Report	Sep 2009	£455
Farmapol Spolka z o.o.-Company Report	Sep 2009	£455
InCode BioPharmaceutics, Inc.-Company Report	Sep 2009	£455
ImuThes Therapeutics Ltd.-Company Report	Sep 2009	£455
EyeGate Pharmaceuticals, Inc-Company Report	Sep 2009	£455
Facet Biotech Corporation-Detailed Product Pipeline	Sep 2009	£455
Fresenius Kabi Oncology Ltd. (formerly Dabur Pharma Limited)-Company Report	Sep 2009	£455
Functional Genetics Inc.-Company Report	Sep 2009	£455
Galenika a.d.-Company Report	Sep 2009	£455
GA Pharmaceuticals SA-Company Report	Sep 2009	£455
Genericon Pharma-Company Report	Sep 2009	£455
Insight Pharmaceuticals Corp.-Company Report	Sep 2009	£455
Gamida Cell Ltd.-Company Report	Sep 2009	£455
Ganeden Biotech, Inc.-Company Report	Sep 2009	£455
FunZyme BioTechnologies S.A.-Company Report	Sep 2009	£455
Greatbatch, Inc.-Deals & Alliances Report	Sep 2009	£365
Garnet BioTherapeutics (formerly Neuronyx, Inc.)-Company Report	Sep 2009	£455
GANYMED Pharmaceuticals AG-Company Report	Sep 2009	£455
Genexo sp. z o.o.-Company Report	Sep 2009	£455
The Government Pharmaceutical Organization-Company Report	Sep 2009	£455
Synerx Pharma-Company Report	Sep 2009	£460
Taejoon Pharma Co., Ltd.-Company Report	Sep 2009	£460
Synergy Healthcare Limited-Company Report	Sep 2009	£460
Ecobi Farmaceutici s.a.s.-Company Report	Sep 2009	£455
Dr. F. Frik Ilac San. Ve Tic. A. S.-Company Report	Sep 2009	£455
Taiwan Biotech Co., Ltd.-Company Report	Sep 2009	£455
Tasly Group-Company Report	Sep 2009	£455
Recordati: Pipeline, Products, Performance, Potential	Sep 2009	£595
Teva Pharmaceutical Industries Limited-Deals & Alliances Report	Sep 2009	£365
TcL Pharma SAS-Company Report	Sep 2009	£455
TCA Cellular Therapy, LLC-Company Report	Sep 2009	£455
Dr. R. Pfleger Chemische Fabrik GmbH-Company Report	Sep 2009	£455
Eagle Pharmaceuticals Pty Ltd-Company Report	Sep 2009	£455
Ecopharm-Company Report	Sep 2009	£455
Eiger BioPharmaceuticals, Inc.-Company Report	Sep 2009	£455
EluSys Therapeutics, Inc.-Company Report	Sep 2009	£455
Star Drugs and Research Labs Ltd.-Company Report	Sep 2009	£455
CytoCore, Inc.-Deals & Alliances Report	Sep 2009	£360
Danaher Corp.-Deals & Alliances Report	Sep 2009	£360
DoNatur GmbH-Company Report	Sep 2009	£455
The Dow Chemical Company-Deals & Alliances Report	Sep 2009	£365
Depomed Inc-Therapeutic Competitors	Sep 2009	£210
Quest Diagnostics Inc.-Deals & Alliances Report	Sep 2009	£360
Vion Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£455
Purzer Pharmaceutical Co. Ltd.-Company Report	Sep 2009	£455
PT Bernofarm-Company Report	Sep 2009	£455
Q-Med AB-Company Report	Sep 2009	£455
Surya Pharmaceutical Limited-Company Report	Sep 2009	£455
Sunways India Pvt. Ltd.-Company Report	Sep 2009	£455
Purdue Pharma L.P-Company Report	Sep 2009	£455
Ensemble Discovery-Company Report	Sep 2009	£455
Therabel Pharma-Company Report	Sep 2009	£455
THE ARAB PHARMACEUTICAL MANUFACTURING CO. LTD. (APM)-Company Report	Sep 2009	£455
Tenet Healthcare Corp.-Deals & Alliances Report	Sep 2009	£365
Theragenics Corp.-Deals & Alliances Report	Sep 2009	£370
Strides Arcolab Limited-Company Report	Sep 2009	£455
Streuli Pharma AG-Company Report	Sep 2009	£455
Shenzhen Mellow Hope Pharm Industrial Co., Ltd.-Company Report	Sep 2009	£455
Spinal Cord Therapeutics GmbH (SCT) (formerly Neuraxo Biopharmaceuticals GmbH)-Company Report	Sep 2009	£455
Skinvisible Inc-Therapeutic Competitors	Sep 2009	£215
Physica Pharma-Company Report	Sep 2009	£460
Thornton and Ross Limited-Company Report	Sep 2009	£460
SpePharm Holding BV-Company Report	Sep 2009	£455
Stewart-Jackson Pharmacal, Inc.-Company Report	Sep 2009	£455
Stem Cell Therapeutics Corp.-Company Report	Sep 2009	£455
Shenzhen Neptunus Interlong Bio-Tech Co., Ltd.-Company Report	Sep 2009	£455
Vanda Pharmaceuticals Inc-Detailed Product Pipeline	Sep 2009	£455
Inovio Biomedical Corporation-Deals & Alliances Report	Sep 2009	£365